Publisher's Synopsis
The field of research in 5-hydroxytryptamine has exploded into furious activity over the past decade and nowhere have the implications been far more reaching than in psychiatry. Thanks largely to the introduction of radioligand binding techniques, a bewildering variety of central 5-hydroxytryptamine receptors has been revealed, and powerful new families of centrally active drugs have emerged. The importance of these new discoveries for psychiatric practice can hardly be exaggerated. To mention but one example, our understanding, and with it the treatment, of obsessive-compulsive disorder has been transformed in a very few years. The excitment continues, and, almost daily, some important new insight, usually drug led, shakes the kaleidoscope and jolts our whole perception of psychiatric illness. In such a heady spirit of the times, the CINP decided to choose 5-hydroxytryptamine and psychiatry as the topic for its first President's Workshop.;The CINP is an international neuropharmacological organization. The record of its first President's Workshop is presented here. The authors are active researchers and have all contributed substantially to the burgeoning 5-hydroxytryptamine field.
